Colon cancer chemoresistance and chemosensitization
| Main Authors: | Shanmugam, M., Dharmarajan, A., Arfuso, Frank, Sethi, G. |
|---|---|
| Format: | Book Chapter |
| Published: |
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/68730 |
Similar Items
Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance
by: Raghunath, A., et al.
Published: (2018)
by: Raghunath, A., et al.
Published: (2018)
Characterization and chemoresistance of HT29 (Colon cancer) and TW06 (Nasopharyngeal cancer) tumorspheres
by: Goh, Iris Wen Li
Published: (2014)
by: Goh, Iris Wen Li
Published: (2014)
Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition
by: Warrier, Sudha, et al.
Published: (2014)
by: Warrier, Sudha, et al.
Published: (2014)
Targeting PDK1 for Chemosensitization of Cancer Cells.
by: Emmanouilidi, A., et al.
Published: (2017)
by: Emmanouilidi, A., et al.
Published: (2017)
Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
by: Adamska, Aleksandra, et al.
Published: (2018)
by: Adamska, Aleksandra, et al.
Published: (2018)
NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
by: Monisha, J., et al.
Published: (2018)
by: Monisha, J., et al.
Published: (2018)
ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
by: Begicevic, R., et al.
Published: (2017)
by: Begicevic, R., et al.
Published: (2017)
Physical exercise as chemosensitizer
by: Vaccarezza, Mauro
Published: (2015)
by: Vaccarezza, Mauro
Published: (2015)
Triterpenoids and sesquiterpenoids for prostate cancer therapy
by: Shanmugam, M., et al.
Published: (2016)
by: Shanmugam, M., et al.
Published: (2016)
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
by: Shanmugam, M., et al.
Published: (2017)
by: Shanmugam, M., et al.
Published: (2017)
Role of RNF20 in cancer development and progression – a comprehensive review
by: Sethi, G., et al.
Published: (2018)
by: Sethi, G., et al.
Published: (2018)
Analysis of the intricate relationship between chronic inflammation and cancer
by: Chai, E., et al.
Published: (2015)
by: Chai, E., et al.
Published: (2015)
First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway
by: Manu, K., et al.
Published: (2012)
by: Manu, K., et al.
Published: (2012)
Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
by: Elaskalani, O., et al.
Published: (2017)
by: Elaskalani, O., et al.
Published: (2017)
Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical review
by: Sethi, G., et al.
Published: (2018)
by: Sethi, G., et al.
Published: (2018)
Evidence for the Involvement of the Master Transcription Factor NF-?B in Cancer Initiation and Progression.
by: Puar, Y., et al.
Published: (2018)
by: Puar, Y., et al.
Published: (2018)
The effects of phenoxodiol on the cell cycle of prostate cancer cell lines
by: Mahoney, S., et al.
Published: (2014)
by: Mahoney, S., et al.
Published: (2014)
γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
by: Rajendran, P., et al.
Published: (2011)
by: Rajendran, P., et al.
Published: (2011)
Possible involvement of long non-coding RNAs GNAS-AS1 and MIR205HG in the modulation of 5-fluorouracil chemosensitivity in colon cancer cells through increased extracellular release of exosomes
by: Azwar, Shamin, et al.
Published: (2024)
by: Azwar, Shamin, et al.
Published: (2024)
Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy
by: Kaboli, Parham Jabbarzadeh, et al.
Published: (2021)
by: Kaboli, Parham Jabbarzadeh, et al.
Published: (2021)
Tumor chemosensitization by physical exercise? Insights from an animal model
by: Vaccarezza, Mauro, et al.
Published: (2015)
by: Vaccarezza, Mauro, et al.
Published: (2015)
Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
by: Kannaiyan, R., et al.
Published: (2011)
by: Kannaiyan, R., et al.
Published: (2011)
The role of resveratrol in cancer therapy
by: Ko, J., et al.
Published: (2017)
by: Ko, J., et al.
Published: (2017)
Redox-responsive chemosensitive polyspermine delivers ursolic acid targeting to human breast tumor cells: The depletion of intracellular GSH contents arouses chemosensitizing effects
by: Ji, X., et al.
Published: (2018)
by: Ji, X., et al.
Published: (2018)
Combatting chemoresistance: an analysis of DNA repair proteins ERCC1 and XPF and their chemotherapeutic implications in ovarian cancer
by: Griffin, Michaela
Published: (2019)
by: Griffin, Michaela
Published: (2019)
Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
by: Ko, J., et al.
Published: (2018)
by: Ko, J., et al.
Published: (2018)
The multifaceted role of curcumin in cancer prevention and treatment
by: Shanmugam, M., et al.
Published: (2015)
by: Shanmugam, M., et al.
Published: (2015)
The Effects of Combination Treatment Using Phenoxodiol and Docetaxel, and Phenoxodiol and Secreted Frizzled-related Protein 4 on Prostate Cancer Cell Lines
by: Mahoney, S., et al.
Published: (2014)
by: Mahoney, S., et al.
Published: (2014)
Exploring the role of multidrug exporters and extracellular vesicles in medulloblastoma chemoresistance
by: Wade, Philippa
Published: (2024)
by: Wade, Philippa
Published: (2024)
Role of epigenetic modulation in cancer stem cell fate
by: Deshmukh, A., et al.
Published: (2017)
by: Deshmukh, A., et al.
Published: (2017)
Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
by: Ip, Carman K.M., et al.
Published: (2016)
by: Ip, Carman K.M., et al.
Published: (2016)
Regulation of cancer stem cell metabolism by secreted frizzled-related protein 4 (SFRP4)
by: Deshmukh, Abhijeet, et al.
Published: (2018)
by: Deshmukh, Abhijeet, et al.
Published: (2018)
Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.
by: Yu, X., et al.
Published: (2014)
by: Yu, X., et al.
Published: (2014)
Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)
by: Chai, E., et al.
Published: (2015)
Role of novel histone modifications in cancer
by: Shanmugam, M., et al.
Published: (2018)
by: Shanmugam, M., et al.
Published: (2018)
Secreted frizzled-related protein 4 and its implications in cancer and apoptosis
by: Pohl, S., et al.
Published: (2015)
by: Pohl, S., et al.
Published: (2015)
Potential anti-inflammatory and anti-cancer properties of farnesol
by: Jung, Y., et al.
Published: (2018)
by: Jung, Y., et al.
Published: (2018)
Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties
by: Bhuvanalakshmi, G., et al.
Published: (2015)
by: Bhuvanalakshmi, G., et al.
Published: (2015)
The Role of Secreted Frizzled Related Protein 4 (sFRP-4) in Regulating Oestradiol-Induced Growth of the MCF-7 Breast Cancer Cell Line
by: McLaren, S., et al.
Published: (2014)
by: McLaren, S., et al.
Published: (2014)
Establishing a Bioluminescent Screening Platform to Identify Stromal-Mediated Chemoresistance in Leukaemia
by: Panting, Rhiannon
Published: (2024)
by: Panting, Rhiannon
Published: (2024)
Similar Items
-
Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance
by: Raghunath, A., et al.
Published: (2018) -
Characterization and chemoresistance of HT29 (Colon cancer) and TW06 (Nasopharyngeal cancer) tumorspheres
by: Goh, Iris Wen Li
Published: (2014) -
Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition
by: Warrier, Sudha, et al.
Published: (2014) -
Targeting PDK1 for Chemosensitization of Cancer Cells.
by: Emmanouilidi, A., et al.
Published: (2017) -
Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
by: Adamska, Aleksandra, et al.
Published: (2018)